|
|
Volumn 115, Issue 1, 2001, Pages 63-65
|
|
Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg™ CMA-676)
a
a
a
a
a
a
a
a
a
a,b
|
|
Author keywords
Acute promyelocytic; CD33; Gemtuzumab ozogamicin; Leukaemia; Molecular remission; PML RAR
|
|
Indexed keywords
ALPHA2B INTERFERON;
AMSACRINE;
ANTHRACYCLINE DERIVATIVE;
ARSENIC TRIOXIDE;
CYTARABINE;
EPIRUBICIN;
ETOPOSIDE;
GEMTUZUMAB OZOGAMICIN;
IDARUBICIN;
IFOSFAMIDE;
METHOTREXATE;
METHYLPREDNISOLONE;
MITOXANTRONE;
RETINOIC ACID;
TIOGUANINE;
ADULT;
ADVANCED CANCER;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CASE REPORT;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
FEMALE;
HUMAN;
MONOTHERAPY;
PRIORITY JOURNAL;
PROMYELOCYTIC LEUKEMIA;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
ADULT;
AMINOGLYCOSIDES;
ANTI-BACTERIAL AGENTS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD;
ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC;
ARSENICALS;
CENTRAL NERVOUS SYSTEM;
COMBINED MODALITY THERAPY;
FEMALE;
GENE REARRANGEMENT;
GENES, MDR;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
LEUKEMIC INFILTRATION;
OXIDES;
TRANSLOCATION, GENETIC;
TRETINOIN;
|
|
EID: 0034773130
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2001.03091.x Document Type: Article |
|
Times cited : (67)
|
|
References (11)
|
